Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus

Lupus

Volumn 19, Issue 2, 2010, Pages 227-228

  Lee, J W ^a   Kim, H A ^a   Sung, J M ^a   Suh, C H ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CD20 ANTIBODY; CYCLOPHOSPHAMIDE; DANAZOL; HEMOGLOBIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; RITUXIMAB; STEROID;

ADULT; AUTOIMMUNE THROMBOCYTOPENIA; CASE REPORT; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG PULSE THERAPY; FEMALE; GINGIVA BLEEDING; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFECTION; LETTER; LEUKOCYTE COUNT; LUPUS VULGARIS; LYMPHOCYTE SUBPOPULATION; MOUTH ULCER; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PETECHIA; PRIORITY JOURNAL; PROTEINURIA; RASH; REFRACTORY IMMUNE THROMBOCYTOPENIA; SIDE EFFECT; SPLENECTOMY; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; URINALYSIS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TREATMENT OUTCOME;

EID: 76049094967     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309345723     Document Type: Letter

References (6)

1. Mestanza-Peralta M., Ariza-Ariza R., Cardiel MH, Alcocer-Varela J. Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus. J Rheumatol 1997 ; 24: 867-870.
2. Miller MH, Urowitz MB, Gladman DD The significance of thrombocytopenia in systemic lupus erythematosus. Arthritis Rheum 1983 ; 26: 1181-1186.
3. Gunnarsson I., Sundelin B., Jonsdottir T., Jacobson SH, Henriksson EW, van Vollenhoven RF Histopathologic and clinical outcome of Rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis. Arthritis Rheum 2007 ; 56: 1263-1272.
4. Perrotta S., Locatelli F., La Manna A., Cennamo L., De Stefano P., Nobili B. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus. Br J Haematol 2002 ; 116: 465-467.
5. Lindholm C., Borjesson-Asp K., Zendjanchi K., Sundqvist AC, Tarkowski A., Bokarewa M. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus. J Rheumatol 2008 ; 35: 826-833.
6. Lehembre S., Macario-Barrel A., Musette P., Carvalho P., Joly P. Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus. Ann Dermatol Venereol 2006 ; 133: 53-55.